Ocular Therapeutix (OCUL) Non-Current Assets (2013 - 2026)

Ocular Therapeutix's Non-Current Assets history runs 14 years deep, the most recent figure standing at $26.5 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 45.58% year-over-year to $26.5 million; the TTM figure through Mar 2026 stood at $94.3 million (up 32.78% YoY), while the FY2025 annual figure was $25.9 million, up 52.99% from the prior year.
• Non-Current Assets was $26.5 million for Q1 2026 at Ocular Therapeutix, up from $25.9 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $26.5 million in Q1 2026 to a low of $12.7 million in Q2 2022.
• Historically, Non-Current Assets has averaged $19.2 million across 5 years, with a median of $19.1 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Non-Current Assets jumped 71.35% in 2023, then declined 17.84% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $19.7 million in 2022, then grew by 0.83% to $19.8 million in 2023, then slipped by 14.51% to $16.9 million in 2024, then surged by 52.99% to $25.9 million in 2025, then grew by 2.34% to $26.5 million in 2026.
• The last three Non-Current Assets figures came in at $26.5 million (Q1 2026), $25.9 million (Q4 2025), and $23.9 million (Q3 2025), per Business Quant data.